Year All202320222021202020192018201720162015201420132012 ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update Aug 09, 2023 ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023 Aug 02, 2023 ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA Jul 19, 2023 ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update May 10, 2023 ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023 May 03, 2023 ADMA Biologics Announces Amendment to Credit Agreement May 02, 2023 ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Mar 23, 2023 ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023 Mar 16, 2023 ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA Feb 08, 2023 ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance Jan 17, 2023
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update Aug 09, 2023
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA Jul 19, 2023
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update May 10, 2023
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Mar 23, 2023
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023 Mar 16, 2023
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA Feb 08, 2023
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance Jan 17, 2023
